PRS28 Adherence to Current Guidelines for Chronic Obstructive Pulmonary Disease (COPD) in Subjects Treated with Combination of Long-Acting β2-Agonist (LABA), LONG-Acting Muscarinic Antagonist (LAMA) or Inhaled Corticosteroids (ICS)
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1415
https://www.valueinhealthjournal.com/article/S1098-3015(11)02977-9/fulltext
Title :
PRS28 Adherence to Current Guidelines for Chronic Obstructive Pulmonary Disease (COPD) in Subjects Treated with Combination of Long-Acting β2-Agonist (LABA), LONG-Acting Muscarinic Antagonist (LAMA) or Inhaled Corticosteroids (ICS)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02977-9&doi=10.1016/j.jval.2011.08.1415
First page :
A492
Section Title :
Respiratory-Related Disorders
Open access? :
No
Section Order :
1367